Scholarly Index
Ralf H. Adams
Max Planck Institute for Molecular Biomedicine; 38,277 total citations; 279 total publications; best world rank #17
Max Planck Institute for Molecular Biomedicine
38,277Total citations
279Total publications
100H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| Angiogenesis and VEGF in Cancer | Lifetime | 31 | DE 3 | 99.71 |
| Axon Guidance and Neuronal Signaling | Lifetime | 17 | DE 3 | 99.45 |
| Hippo pathway signaling and YAP/TAZ | Lifetime | 33 | DE 1 | 98.79 |
| Zebrafish Biomedical Research Applications | Lifetime | 56 | DE 7 | 98.70 |
| Congenital heart defects research | Lifetime | 275 | DE 17 | 97.85 |
| Lymphatic System and Diseases | Lifetime | 120 | DE 8 | 96.81 |
| Apelin-related biomedical research | Lifetime | 370 | DE 20 | 91.38 |
| Kruppel-like factors research | Lifetime | 541 | DE 29 | 91.23 |
| Barrier Structure and Function Studies | Lifetime | 480 | DE 55 | 91.21 |
| Bone Metabolism and Diseases | 2021-2025 | 342 | DE 14 | 83.61 |
| Barrier Structure and Function Studies | 2021-2025 | 293 | DE 25 | 70.30 |
| Angiogenesis and VEGF in Cancer | 2021-2025 | 573 | DE 24 | 65.15 |
| Axon Guidance and Neuronal Signaling | 2021-2025 | 258 | DE 16 | 59.79 |
| Kruppel-like factors research | 2021-2025 | 603 | DE 27 | 57.80 |
| Apelin-related biomedical research | 2021-2025 | 432 | DE 11 | 53.62 |